Parents mark £10,000 fundraising milestone after loss of son, Khushil, to a brain tumour
Namrata and Bhavesh Pandya, from Harrow, are calling for more research into DIPG brain tumours
A genetic mutation causing DMG and a potential drug to treat it
Geneticists from Trinity College Dublin have discovered how a specific genetic mutation called H3K27M causes a devastating, incurable childhood cancer, known as diffuse midline glioma (DMG), and, in lab studies working with model cell types, successfully reverse its effects to slow cancer cell growth with a targeted drug.
New treatments for diffuse midline gliomas
A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)